Table 4.
Metabolic disorders in different gender subjects
Male |
Female |
|||||||
---|---|---|---|---|---|---|---|---|
NGT | IFG/IGT | T2D | P value for trends | NGT | IFG/IGT | T2D | P value for trends | |
N |
1559 |
1172 |
3376 |
|
782 |
296 |
2072 |
|
Abnormal Blood Pressure |
556 (35.6%) |
672 (57.3%)*** |
1879 (55.5%)*** |
<0.001 |
169 (21.4%)&&& |
112 (37.8%)***&&& |
1165 (56.2%)***### |
<0.001 |
95%CI |
(33.2–38.0) |
(54.5–60.2) |
(53.9–57.2) |
(18.5–24.2) |
(32.3–43.4) |
(53.8-58.1) |
||
Odds Ratio |
Ref |
2.420(2.072–2.826) |
2.255(1.993–2.552) |
Ref |
2.198(1.646–2.937) |
4.648(3.840-5.626) |
||
Hypertension |
382 (24.5%) |
506 (43.2%)*** |
1345 (39.8%)***# |
<0.001 |
108 (13.8%)&&& |
77 (26.0%)***&&& |
915 (44.0%)***###&& |
<0.001 |
95%CI |
(22.3–26.6) |
(40.3–46.0) |
(38.1–41.4) |
(11.4–16.2) |
(21.0–31.0) |
(41.8-46.1) |
||
Odds Ratio |
Ref |
2.334(1.983–2.748) |
2.035(1.779–2.328) |
Ref |
2.187(1.573–3.041) |
4.931(3.954-6.149) |
||
Central obesity |
392 (25.1%) |
497 (42.2%)*** |
1716 (50.8%)***### |
<0.001 |
248 (31.6%)&& |
129 (43.2%)*** |
1459 (70.4%)***###&&& |
<0.001 |
95%CI |
(22.9–27.2) |
(39.4–45.1) |
(49.1–52.5) |
(28.3–34.9) |
(37.6–48.9) |
(68.2-72.2) |
||
Odds Ratio |
Ref |
2.186(1.858–2.572) |
3.066(2.685–3.501) |
Ref |
1.656(1.259–2.178) |
5.097(4.269-6.086) |
||
Overweight & Obesity |
513 (32.9%) |
599 (51.1%)*** |
1614 (47.8%)*** |
<0.001 |
149 (19.1%)&&& |
77 (26.0%)**&&& |
835 (40.3%)***###&&& |
<0.001 |
95%CI |
(31.0–35.0) |
(48.0–54.0) |
(46.0–49.0) |
(16.0–22.0) |
(21.0–31.0) |
(38.0-42.0) |
||
Odds Ratio |
Ref |
2.124(1.818–2.482) |
1.862(1.643–2.110) |
Ref |
1.490(1.087–2.041) |
2.867(2.350-3.498) |
||
Abnormal Triglycerides |
672 (43.1%) |
669 (57.1%)*** |
2010 (59.5%)*** |
<0.001 |
144 (18.4%)&&& |
111 (37.5%)***&&& |
1079 (52.1%)***###&&& |
<0.001 |
95%CI |
(40.6–45.5) |
(54.0–59.7) |
(57.7–61.1) |
(15.7–21.1) |
(32.0–43.1) |
(49.5-53.8) |
||
Odds Ratio |
Ref |
1.749(1.501–2.038) |
1.934(1.713–2.184) |
Ref |
2.646(1.968–3.559) |
4.806(3.934-5.871) |
||
Abnormal HDL cholesterol |
718 (46.1%) |
687 (58.6%)*** |
2349 (69.6%)***### |
<0.001 | 286 (36.6%)&&& |
157 (53.0%)*** |
1455 (70.2%)***### |
<0.001 |
|
(43.5–48.5) |
(55.5–61.2) |
(67.9–71.0) |
(33.8–40.6) |
(48–59.4) |
(68.7-72.7) |
||
Odds Ratio | Ref | 1.653(1.419–1.926) | 2.662(2.353–3.012) | Ref | 1.947(1.486–2.550) | 4.070(3.424-4.838) |
Compared with NGT *P<0.05, **P<0.01, ***P<0.001; Compared with IFG/IGT #P<0.05, ##P<0.01, ###P<0.001; Compared with male group &P<0.05, &&P<0.01, &&&P<0.001.